Shown to be 79% safe and effective.

A new experiment paves the way for the approval of the AstraZeneca vaccine in America

Taiwan's Health Minister receives the AstraZeneca vaccine yesterday.

EPA

The AstraZeneca vaccine to prevent the emerging corona virus (Covid-19) received a big boost, yesterday, after extensive trial data showed that it was 79% safe and effective in preventing symptomatic Covid-19 infection, paving the way for its emergency use. In the United States, while countries in Asia are speeding up its vaccination campaigns.

The British-Swedish pharmaceutical company, AstraZeneca, announced that a new examination of its anti-Corona vaccine did not show any increase in the risk of blood clots by receiving the vaccine, and the company said in a statement yesterday that an independent group of experts had not detected any safety concerns.

A study conducted on about 32,500 thousand people in the United States, Chile and Peru confirmed the high efficacy of the vaccine, and the company confirmed that the vaccine protects against Corona with an efficacy of 79%, and for people over the age of 65, this percentage reaches 80%.

The company announced that the efficacy in all age groups, in relation to the development of the disease to severe complications, reaches 100%, and the company announced that it would apply to the American Drug Administration to obtain emergency approval to circulate its vaccine.

The vaccine, called AZD1222, was developed by «AstraZeneca» in cooperation with the University of Oxford in Britain, and has been used widely in the United Kingdom since last January.

British Health Secretary Matt Hancock spoke of "more good news".

Hancock said on the social networking site "Twitter": "The results of an American examination of the Oxford / AstraZeneca vaccine clearly show that the vaccine is safe and very effective."

The "AstraZeneca" vaccine was among the first and cheapest "Covid-19" vaccines that were developed and mass-produced, and it is set to become a basic vaccine in vaccination programs in many countries.

Taiwanese Prime Minister Su Tsing-chang told reporters at the start of the vaccination campaign in his country yesterday, "I took a dose of the vaccine (AstraZeneca), there is no pain at the injection site and no pain in the body."

Taiwanese Health Minister Chen Shih-chung also received a dose of AstraZeneca vaccine in one of the 57 hospitals designated for vaccination operations in various parts of Taiwan.

The Thai Prime Minister was also the first to receive the AstraZeneca vaccine in his country, and South Korean President Moon Jae-in (68 years) intends to receive the dose today, and told his country's citizens: “The vaccination is not only to protect yourself, but to protect our society as a whole through herd immunity.” .

And at the end of last week, the European Medicines Agency considered the vaccine "safe and effective."

The British and Europeans exchanged accusations of seizing the doses that are manufactured on their lands, and in response to the British Defense Minister Ben Wallace's warning to the European Union not to adhere to the vaccine contracts, after the European Commission threatened to halt exports of "AstraZeneca" if the European Union did not receive its shipments first, the President of the European Commission said. Ursula von der Leyen, “The Commission has its own contract with (AstraZeneca).

It has received less than 10% of the expected doses this year under the contract.

Consequently, it is natural for the Commission to demand that the doses be received as expected. ”

Von der Leyen recalled that the European Union’s contract with «AstraZeneca» provides for the delivery of industrial doses on its territory and in Britain.

"But we have not received anything from the British, while we are providing them with the doses," she said.

The AstraZeneca vaccine is manufactured on European soil, especially in two laboratories in Belgium and the Netherlands.

In addition, the European Commissioner for the Internal Market, Thierry Breton, said that Europe could reach herd immunity on July 14, confirming the expected increase in vaccine delivery.

He added on the French Channel One: "Let's take a symbolic date: next July 14, we have the possibility to achieve immunity on the continent."

He explained: «It is a straight road because we know that to overcome this epidemic there is only one solution: vaccination.

Vaccines are coming, they will be here ».

He stressed that between this March and next June, the European Union will receive between 300 and 350 million doses of vaccines, indicating that 55 factories are now working to manufacture vaccines in Europe.

• A European commissioner expects to achieve immunity across the continent next July.

Follow our latest local and sports news, and the latest political and economic developments via Google news